l General Information |
Product Name | MLR-1023 |
General description | MLR-1023 is a Lyn kinase activator and a novel insulin receptor potentiator that elicits a rapid-onset and durable improvement in glucose homeostasis in animal models of type 2 diabetes. |
Synonym | Tolimidone, CP-26154; 5-(3-methylphenoxy)-1H-pyrimidin-2-one |
Purity | ≥98.5%(HPLC) | CAS Number | 41964-07-2 |
Formula | C11H10N2O2 | Molecular Weight | 202.21 |
Suitability | BioReagent, suitable for cell culture, etc. |
l Physical and Chemical Information |
Appearance | White to beige Solid |
Solubility(25°C) | DMSO | ≥35mg/mL |
Ethanol | ≥15mg/mL |
Water | Very slightly soluble |
l Storage |
Storage temp. | -20°C |
l Precautions and Disclaimer |
This product is for R&D use only, not for drug, household, or other uses. |
l References |
1. http://www.drugbank.ca 2. https://ncit.nci.nih.gov 3. https://www.ncbi.nlm.nih.gov |
